BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9669770)

  • 1. Detection of prostate and colon cancer.
    Stern S; Altkorn D; Levinson W
    JAMA; 1998 Jul; 280(2):117-8. PubMed ID: 9669770
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening in the new environment of medicine: questions and answers.
    Mt Sinai J Med; 1995 Sep; 62(4):262-3. PubMed ID: 7565848
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum ferritin and stool occult blood and colon cancer screening.
    Griffiths EK; Schapira DV
    Cancer Detect Prev; 1991; 15(4):303-5. PubMed ID: 1794137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Counseling patients about prostate cancer screening.
    Foxhall LE; Von Eschenbach AC
    Am Fam Physician; 2002 May; 65(9):1752, 1754, 1757. PubMed ID: 12018801
    [No Abstract]   [Full Text] [Related]  

  • 5. The United States Preventive Services Task Force recommendation against prostate-specific antigen screening--point.
    Ablin RJ
    Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):391-4. PubMed ID: 22315362
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostate cancer screening.
    Med Lett Drugs Ther; 2008 Nov; 50(1298):85-6. PubMed ID: 18978703
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening and detection of colon cancer.
    Schubert TT
    Mo Med; 1986 Mar; 83(3):145-50. PubMed ID: 3333815
    [No Abstract]   [Full Text] [Related]  

  • 8. Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.
    Schröder FH
    N Engl J Med; 2011 Nov; 365(21):1953-5. PubMed ID: 22029756
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostate-cancer screening--what the U.S. Preventive Services Task Force left out.
    Brett AS; Ablin RJ
    N Engl J Med; 2011 Nov; 365(21):1949-51. PubMed ID: 22029759
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of cancer of the colon--a review of faecal occult blood screening.
    Sangster JF
    Fam Pract; 1986 Dec; 3(4):259-65. PubMed ID: 3542680
    [No Abstract]   [Full Text] [Related]  

  • 11. Indications for PSA testing.
    Barry MJ; Roberts RG
    JAMA; 1997 Mar; 277(12):955-6. PubMed ID: 9091657
    [No Abstract]   [Full Text] [Related]  

  • 12. Save your life: cancer screening is oversold. Know the tests to get--and those to skip.
    Consum Rep; 2013 Mar; 78(3):28-33. PubMed ID: 23556197
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of colon cancer.
    Hill MJ
    Eur J Cancer Prev; 1997 Apr; 6(2):105-6. PubMed ID: 9237056
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness of colon cancer screening.
    Lieberman D
    Am J Gastroenterol; 1991 Dec; 86(12):1789-94. PubMed ID: 1962624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for prostate cancer: yes or no?
    Green ME
    Postgrad Med; 1996 Dec; 100(6):39-40. PubMed ID: 8960008
    [No Abstract]   [Full Text] [Related]  

  • 16. PSA thresholds for prostate cancer detection.
    Parker ME
    JAMA; 1997 Sep; 278(9):699-700; author reply 700-1. PubMed ID: 9286820
    [No Abstract]   [Full Text] [Related]  

  • 17. PSA screening and prostate cancer risk reduction.
    Andriole GL
    Urol Oncol; 2012; 30(6):936-7. PubMed ID: 23218069
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for prostate cancer: the role of prostate-specific antigen.
    Ferrer RL
    Md Med J; 1996 Nov; 45(11):938-40. PubMed ID: 8942171
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening in the new environment of medicine: colon and prostate cancer. Introduction.
    Gilbert PL
    Mt Sinai J Med; 1995 Sep; 62(4):251. PubMed ID: 7565845
    [No Abstract]   [Full Text] [Related]  

  • 20. Early detection of prostate cancer. Role of prostate-specific antigen.
    Prabhakaran VM
    Can Fam Physician; 1996 Apr; 42():709-12. PubMed ID: 8653039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.